Spots Global Cancer Trial Database for Brevera™ Breast Biopsy System Data Collection Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Brevera™ Breast Biopsy System Data Collection Study
Official Title: A Prospective Study To Evaluate The Performance And Operation Of The Brevera™ Breast Biopsy System
Study ID: NCT03456583
Conditions
Interventions
Study Description
Brief Summary: The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Institut régional du Cancer de Montpellier, Montpellier, , France
Brustdiagnostik Munchen, Tübingen, , Germany
Radiologia Senologica, Milan, , Italy
Noordwest Ziekenhuisgroep, Alkmaar, , Netherlands
Centro de Patalogia de la Mama-Fundacion Tejerina, Madrid, , Spain
Royal Free Londan NHS Foundation Trust, London, , United Kingdom
Contact Details
Name: Brad Keller
Affiliation: Hologic, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
